The research in the past ten years shows that the incidence of malignant tumors in dialysis patients is signifi cantly higher than that in normal people. The highest proportion of urinary tumors is one of the main causes of death in patients with end-stage renal disease, and the incidence is gradually increasing. However, the high-risk factors of urinary tract tumors in dialysis patients have not yet been fully elucidated, so exploring this issue is an important issue that the medical community needs to solve. The objectives of this study are to understand the clinical characteristics of maintenance dialysis patients with urinary tract tumors and the infl uence of related factors on their prognosis.
Introduction
Epidemiological studies have shown that the incidence of malignant tumors in maintenance dialysis patients is relatively high, with urinary bladder tumors being the most common. Maintenance hemodialysis patients often require surgical treatment for complicated urinary tumors. This study investigated the clinical features of urinary tract tumors in patients with MHD Correspondence Hui Xu, Department of Urology, the Affi liated Hospital of Chengde Medical College, Chengde,Hebei,China, email:chengdexuhui@163.com. and related factors that infl uence the prognosis of patients.
Methods

Study design and settings:
Cross-sectional survey of 912 patients with renal dysfunction with maintenance dialysis greater than 3 months, analysis of clinical data of 22 patients with urinary tumors, including age of renal failure, age of confi rmed tumor, dialysis time,
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Nepalese Journal of Cancer (NJC) 10 dialysis-tumor time, urea nitrogen before fi rst dialysis, creatinine before fi rst dialysis, albumin before fi rst dialysis, hemoglobin before fi rst dialysis, hemoglobin during dialysis, albumin during dialysis, imaging fi ndings of tumor, tumor condition, surgical treatment, postoperative pathological results prognosis (recovery of tumor or postoperative survival time) and cause of death. 
Results
Among the 912 patients with maintenance dialysis, 22 patients had urinary tumors with an incidence of 2.41%. Among them, 12 patients were bladder tumors, 3 patients were renal pelvic tumors, 4 patients were ureteral tumors, 2 patients were renal tumors, and 1 patient was prostate cancer. There were 17 cases of intermittent and painless gross hematuria, 2 cases of gross hematuria, 1 case of lumbar pain, 1 case of abdominal pain and dysuria, 1 case of frequent urination and dysuria, as shown in table l. Ten patients underwent surgical treatment, including 2 cases of renal ureteral cystectomy, 8 cases of transurethral resection of bladder tumor; 9 cases of postoperative pathology were high-grade urothelial carcinoma, 1 case was papilloma; 4 cases had died. The postoperative survival period was 12~103 months, with an average of 58.75 months. The 5-year survival rate of patients after surgery was 50%. 12 patients were unable to undergo surgery due to other diseases or economic reasons; 9 patients died and the tumor was found to die from 14~38 months, with an average of 24.11 month. The cause of death in patients: 5 cases of myocardial infarction, 3 cases of heart failure, 3 cases of tumor metastasis, 2 cases of serious infection. Single-factor correlation analysis was used to screen the relevant variables collected. According to the results of single-factor correlation analysis, the urea nitrogen before the fi rst dialysis, the creatinine before the fi rst dialysis, the albumin before the fi rst dialysis, the hemoglobin before the fi rst dialysis, the hemoglobin during the dialysis. Blood albumin and variables were substituted into the logistic regression equation during dialysis. The results showed: urea nitrogen before the fi rst dialysis, creatinine before the fi rst dialysis, hemoglobin before the fi rst dialysis, hemoglobin during dialysis, and albumin during dialysis were independent risk factors for tumorigenesis (P<0.05), of which urea nitrogen before the fi rst dialysis. There was a positive correlation between creatinine before the fi rst dialysis, hemoglobin before the fi rst dialysis, hemoglobin during dialysis, and a negative correlation between serum albumin levels during dialysis, as shown in table 2. 
Discussion
The study found that patients with maintenance dialysis have a higher risk of malignancy and the highest proportion of urinary tumors. 1 Gao Yan et al 2 retrospectively analyzed the clinical data of 103 patients with maintenance dialysis, and found 12 cases of malignant tumors, the incidence rate was 11.65%; 5 cases of urinary system tumors (3 cases of renal cell carcinoma, 2 cases of bladder cancer) ), the highest incidence, accounting for 41.67% of all malignant tumors. As in previous reports, our results indicate a high incidence of urinary tumors in maintenance dialysis patients (2.41%). In addition, the incidence of urothelial cancer in maintenance dialysis patients is very high compared to the general population.
Factors affecting urinary tract tumors in dialysis patients are multifaceted: studies have found that, 3 maintenance dialysis and urinary tumor patients with hemoglobin levels compared with patients without urinary tumors, the difference is statistically signifi cant, suggesting tumor occurred in association with hypohemoglobinemia. Gao Yan et al believe that albumin less than 30g is also an independent risk factor for maintenance dialysis and malignant tumors. 2 In this study, the albumin and hemoglobin of dialysis patients with urinary tract tumors were compared with dialysis patients without concurrent tumors. The results showed statistically signifi cant differences (P<0.05). This further validates the level of albumin and hemoglobin in dialysis patients associated with the development of urinary tumors. In addition to the above factors, dialysis age greater than 6 years is also an independent risk factor for maintenance dialysis and malignant tumors. 4 In addition, with the decline of renal function, urine scouring effect on the urethra is signifi cantly weakened, while the metabolic toxin in the body increases the stimulation of the urinary tract, and the concentration of cytokeratin 18 (the urothelial tumor marker CK18) in the urine. The increase may also be the cause of high incidence of urinary tract tumors in dialysis patients; 5 Studies have also shown, 6 the increase of genomic damage caused by DNA repair dysfunction in dialysis patients is also the cause of high incidence of dialysis combined with urinary tumors; Accumulation and release of uremic toxins such as creatinine, urea nitrogen, parathyroid hormone, beta microglobulin, and sulphuric acid phenol during dialysis, as well as an increase in genotoxic infl ammatory cytokines (such as tumor necrosis factor) can lead to the occurrence of urinary tumors. Some scholars believe that the susceptibility of dialysis patients to oncogenic viruses is related to uremia immunodefi ciency, which is characterized by impaired monocyte function, and defective T cell activation leads to reduced immune surveillance, which may also be the cause of high incidence of urinary tumors in dialysis patients . 7 Similar to previous studies, painless gross hematuria is the main symptom in our report. The main diagnostic procedures include cystoscopy, re-sonography, and retrograde pyelography; urine cytology has a high false-negative rate, which is not the fi rst choice for the diagnosis of urothelial cancer. Surgical resection was still the gold standard for maintenance dialysis patients; The mean postoperative survival was 58.75 months, and only one patient died directly from TCC. Due to the high incidence of urinary tumors in maintenance dialysis patients, the hematuria of dialysis patients should not be ignored, should be regarded as a symptom of urinary tumors, should be further diagnosed. Early detection and diagnosis and aggressive surgical intervention can yield satisfactory results.
For urinary tumors found early in maintenance dialysis, surgical treatment should be actively performed if all conditions permit. The mean postoperative survival (58.75 months) was signifi cantly higher in the study than in those who did not (24.71 months). Kang et al suggest that prophylactic cystectomy should be considered in patients with end-stage renal disease undergoing maintenance dialysis with urothelial carcinoma because of the high incidence of nonfunctioning urinary tract tumors. 8 Some scholars believe that for patients with maintenance dialysis combined with only one side of urothelial carcinoma, unilateral urethroplasty is feasible; For patients with maintenance dialysis and myometrial invasive bladder cancer, it is diffi cult to treat residual urine after total bladder resection. Road monitoring, it is necessary to actively perform a primary urinary tract resection; For patients with multifocal urothelial carcinoma, staged urethral resection may be the best choice . 9 Studies have reported that the mean and median survival of patients undergoing total urography with maintenance dialysis and urothelial carcinoma were 27.5 and 17.5 months, respectively. 9 In this study, the 5-year survival rate (50%) of maintenance dialysis patients with urinary tract resection was better than that of patients without surgery (27.3%). It has been reported in the literature that 9 the Charlson Comorbidity Index (CCI) is used as an indicator for assessing preoperative conditions in patients and is closely related to postoperative survival rate; 90day mortality in maintenance dialysis patients with urinary tumors along with CCI the increase in value increased. When the CCI values were 0, 1, 2, and ≥ 3, the patient mortality rates were 6.3%, 10.3%, 12.6%, and 15.9%, respectively. Therefore, CCI is important for the maintenance of dialysis patients with urinary tumors, and should be considered when evaluating the prognosis of patients with maintenance dialysis and urinary tumors.
Conclusion
The high incidence of urinary tumors in maintenance dialysis patients has been confi rmed by domestic and foreign research centers, but the reasons have not yet been fully elucidated. Attention should be paid to the monitoring of urinary tract tumors in maintenance dialysis patients, especially in elderly patients without cardiovascular and cerebrovascular complications. Once urinary tract tumors are found, surgical treatment should be actively performed because they can achieve longer life.
